Jeffrey T. Barnes

Criticare designs, Inc. manufactures and markets vital signs and gas monitoring instruments and related noninvasive sensors used to monitor patients in many healthcare environments. Their products also provide readings for electrocardiograms and monitor oxygen saturation, carbon dioxide levels, blood pressure, temperature, heart rate, and respiration rate. The company also makes reusable pulse oximetry sensors for use with its equipment. Criticare sells its products to hospitals, nursing homes and physician offices in the U.S. and abroad. The firm was founded in 1984 and is located in Waukesha, WI.

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

RS Investment Management Co. LLC (also known as RS Investments) is an investment advisor and mutual fund manager headquartered in San Francisco, California. Founded in 1986, the firm was acquired by Victory Capital Management, Inc. from The Guardian Life Insurance Co. of America in July 2016. They operate as an independent franchise within Victory Capital's multi-boutique model. Each of the teams within the RS franchise continues to operate autonomously. RS Investments provides investment advisory services to mutual funds, institutions, private pooled investment vehicles, and high net-worth individuals.

IntraPace, Inc. develops systems for the treatment of obesity. These also track patient activity levels, providing an overview of food consumption and exercise trends. The company was founded in 2001 and is headquartered in San Jose, CA.

HydroCision, Inc. develops, manufactures and markets fluid-jet based surgical tools. Its products include spinejet system, spinejet XL, hydrodiscectomy system and allograft system. The company was founded by Kevin P. Staid and Timothy E. Moutafis in 1994 and is headquartered in North Billerica, MA.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

FlowMedica, Inc. develops intravascular systems and medical devices. The company's products include Benephit CV, PVSolo, PVMini, and XT Infusion systems. It also develops novel, proprietary, and minimally invasive intravascular systems for implementing Targeted Renal Therapy. The company was founded in 2002 and is headquartered in Fremont, CA.

Cambridge Endoscopic Devices, Inc. manufactures surgical and medical devices. It offers an autonomy laparo-angle articulating instrument technology. The patented Autonomy product line offers access to difficult areas and improved tip positioning and control during surgical procedures. The company was founded by Woojin Lee and Jack Jacobson in 2004 and is headquartered in Framingham, MA.